A poster titled "Posters on Utilizing HTPD and DoE to Optimize the Pharmaron Gene Therapy Platform." There is a smaller image of a detailed poster, highlighting bioanalytical development. A "Download Posters Below" button is present, with the Pharmaron logo and text in Chinese characters at the bottom right.

Utilising HTPD and DoE to Optimise the Pharmaron Gene Therapy Platform

At Pharmaron, we have successfully developed a platform process for the creation of AAV gene therapies with a highly adaptive toolbox to manage varying AAV products and serotypes. Our toolbox can rapidly assess a product’s fit to our platform and finely tune a number of parameters for targeted optimisation.

To learn more about how HTPD and DoE can optimise our Gene Therapy Platform, please complete the form below to download the poster: Utilising HTPD and DoE to Optimise the Pharmaron Gene Therapy Platform.